Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$78,476
-$6,833 QoQ
Shares Held
309
-11.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#4,591
of 4,676 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kilter Group LLC holds $1,385,854 across 15 Drug Manufacturers - General names. JNJ ranks #4 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
1,490 | $539,558 | |
| 2 | LLY |
ELI LILLY & Co
|
287 | $344,236 | |
| 3 | ABBV |
AbbVie Inc.
|
498 | $125,316 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
309 | $78,476 | |
| 5 | MRK |
Merck & Co., Inc.
|
480 | $61,680 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
360 | $45,482 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
605 | $34,860 | |
| 8 | NVS |
Novartis AG
|
209 | $32,754 |
All Filings in JNJ
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,476 | 309 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $85,309 | 349 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $55,876 | 270 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $121,635 | 656 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $85,234 | 558 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||